PubRank

M J Osborn

Author PubWeight™ 143.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mechanism of assembly of the outer membrane of Salmonella typhimurium. Isolation and characterization of cytoplasmic and outer membrane. J Biol Chem 1972 29.60
2 Structure and biosynthesis of the bacterial cell wall. Annu Rev Biochem 1969 5.24
3 Proteins of the outer membrane of gram-negative bacteria. Annu Rev Microbiol 1980 5.05
4 Separation of the inner (cytoplasmic) and outer membranes of Gram-negative bacteria. Methods Enzymol 1974 4.87
5 Mechanism of assembly of the outer membrane of Salmonella typhimurium. Site of synthesis of lipopolysaccharide. J Biol Chem 1972 4.04
6 Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 1979 3.58
7 Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1997 2.37
8 Enzymes of phospholipid metabolism: localization in the cytoplasmic and outer membrane of the cell envelope of Escherichia coli and Salmonella typhimurium. Biochim Biophys Acta 1971 2.28
9 Translocation of phospholipids between the outer and inner membranes of Salmonella typhimurium. J Biol Chem 1977 2.26
10 Biosynthesis of bacterial lipopolysaccharide. V. Lipid-linked intermediates in the biosynthesis of the O-antigen groups of Salmonella typhimurium. Proc Natl Acad Sci U S A 1965 2.00
11 Lateral mobility in reconstituted membranes--comparisons with diffusion in polymers. Nature 1980 1.99
12 An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium. Proc Natl Acad Sci U S A 1983 1.95
13 Properties of the O-specific hapten formed in vivo by mutant strains of Salmonella typhimurium. Biochemistry 1968 1.88
14 Localization of the terminal steps of O-antigen synthesis in Salmonella typhimurium. J Bacteriol 1991 1.77
15 Lipid A mutants of Salmonella typhimurium. Purification and characterization of a lipid A precursor produced by a mutant in 3-deoxy-D-mannooctulosonate-8-phosphate synthetase. J Biol Chem 1977 1.75
16 Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation. Pediatrics 2001 1.75
17 Lipopolysaccharide and aldoheptose biosynthesis in transketolase mutants of Salmonella typhimurium. Proc Natl Acad Sci U S A 1971 1.75
18 Interaction of Salmonella typhimurium with phospholipid vesicles. Incorporation of exogenous lipids into intact cells. J Biol Chem 1977 1.73
19 Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol 1977 1.58
20 Multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1995 1.57
21 Pyopneumopericardium attributed to an esophagopericardial fistula: report of a survivor and review of the literature. Mayo Clin Proc 1991 1.54
22 Lipid A mutants of Salmonella typhimurium. Characterization of a conditional lethal mutant in 3-deoxy-D-mannooctulosonate-8-phosphate synthetase. J Biol Chem 1977 1.52
23 Mechanism of assembly of the outer membrane of Salmonella typhimurium. Translocation and integration of an incomplete mutant lipid A into the outer membrane. J Biol Chem 1980 1.48
24 Extraction of the Telectronics Accufix 330-801 atrial lead: the Mayo Clinic experience. Mayo Clin Proc 1996 1.45
25 Arrhythmogenic right ventricular dysplasia masquerading as dilated cardiomyopathy. Am J Cardiol 1999 1.44
26 Effects of slow pathway ablation on fast pathway function in patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1997 1.44
27 Isolation of a mutant of Salmonella typhimurium dependent on D-arabinose-5-phosphate for growth and synthesis of 3-deoxy-D-mannoctulosonate (ketodeoxyoctonate). Proc Natl Acad Sci U S A 1972 1.43
28 Isolation of mutants conditionally blocked in the biosynthesis of the 3-deoxy-D-manno-octulosonic-acid--lipid-A part of lipopolysaccharides derived from Salmonella typhimurium. Eur J Biochem 1977 1.36
29 Enzymatic incorporation of N-acetylglucosamine into cell wall lipopolysaccharide in a mutant strain of Salmonella typhimurium. Biochem Biophys Res Commun 1964 1.36
30 Biochemical characterization of mutants of Salmonella typhimurium lacking glucosyl or galactosyl lipopolysaccharide transferases. Nature 1968 1.35
31 Characterization of the cell wall lipopolysaccharide of a mutant of Salmonella typhimurium lacking phosphomannose isomerase. Biochem Z 1965 1.29
32 Biosynthesis of a bacterial lipopolysaccharide. VI. Mechanism of incorporation of abequose into the O-antigen of Salmonella typhimurium. J Biol Chem 1968 1.26
33 Biosynthesis of lipid A. Enzymatic incorporation of 3-deoxy-D-mannooctulosonate into a precursor of lipid A in Salmonella typhimurium. J Biol Chem 1978 1.25
34 Biochemical aspects of structure, differentiation and morphogenesis in microorganisms. Mechanism of biosynthesis of the lipopolysaccharide of Salmonella. Fed Proc 1967 1.23
35 Structure and biogenesis of the cell envelope of gram-negative bacteria. Ann N Y Acad Sci 1974 1.22
36 Update on infections involving permanent pacemakers. Characterization and management. J Thorac Cardiovasc Surg 1985 1.19
37 Cardiac histologic findings in patients with life-threatening ventricular arrhythmias of unknown origin. J Am Coll Cardiol 1984 1.19
38 Biosynthesis of bacterial lipopolysaccharide. VII. Enzymatic formation of the first intermediate in biosynthesis of the O-antigen of Salmonella typhimurium. J Biol Chem 1968 1.18
39 Transport of D-arabinose-5-phosphate and D-sedoheptulose-7-phosphate by the hexose phosphate transport system of Salmonella typhimurium. J Bacteriol 1974 1.16
40 Phosphoheptose isomerase, first enzyme in the biosynthesis of aldoheptose in Salmonella typhimurium. J Biol Chem 1974 1.16
41 Hemodynamic and symptomatic consequences of ventricular pacing. Pacing Clin Electrophysiol 1982 1.11
42 Propafenone for paroxysmal atrial fibrillation. Am J Cardiol 1988 1.08
43 Biosynthesis and structure of the core region of the lipopolysaccharide in Salmonella typhimurium. Ann N Y Acad Sci 1966 1.02
44 Further studies on enzymatic synthesis of O-antigen in Salmonella typhimurium. Biochemistry 1968 1.01
45 A microbiological study of non-gonococcal proctitis in passive male homosexuals. Postgrad Med J 1981 1.01
46 Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc 1994 1.00
47 Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol 2001 1.00
48 Electrophysiologic testing in the upright position: improved evaluation of patients with rhythm disturbances using a tilt table. J Am Coll Cardiol 1984 0.99
49 Energy dependence of O-antigen synthesis in Salmonella typhimurium. J Bacteriol 1991 0.99
50 Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc 1985 0.98
51 Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 1996 0.97
52 Galactose Incorporation into Cell-Wall Lipopolysaccharide in Mutant Strain of Salmonella typhimurium. Science 1962 0.96
53 Haptenic O-antigen as a polymeric intermediate of in vivo synthesis of lipopolysaccharide by Salmonella typhimurium. Biochemistry 1968 0.95
54 The Dotter retriever and pigtail catheter: efficacy in extraction of chronic transvenous pacemaker leads. Pacing Clin Electrophysiol 1993 0.93
55 Lateral diffusion of lipopolysaccharide in the outer membrane of Salmonella typhimurium. Nature 1980 0.93
56 Biosynthesis of lipid A. Formation of acyl-deficient lipopolysaccharides in Salmonella typhimurium and Escherichia coli. J Biol Chem 1980 0.93
57 Genetic analysis of treated and untreated phenylketonuria in one family. J Med Genet 1990 0.92
58 Energy dependence of lipopolysaccharide translocation in Salmonella typhimurium. J Biol Chem 1985 0.90
59 Biosynthesis of lipid A. In vivo formation of an intermediate containing 3-deoxy-D-mannoctulosonate in a mutant of Salmonella typhimurium. J Biol Chem 1980 0.90
60 Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block. Am J Cardiol 1987 0.90
61 Biosynthesis of O-antigen in Salmonella typhimurium. Ann N Y Acad Sci 1966 0.88
62 Permanent cardiac pacing after the Fontan procedure. J Thorac Cardiovasc Surg 1985 0.88
63 Identification of the haplotype pattern associated with the mutant PKU allele in the Gypsy population of Wales. J Med Genet 1989 0.86
64 Increased vagal tone as an isolated finding in patients undergoing electrophysiological testing for recurrent syncope: response to long term anticholinergic agents. Br Heart J 1986 0.86
65 Evidence for energy-dependent transposition of core lipopolysaccharide across the inner membrane of Salmonella typhimurium. J Bacteriol 1991 0.85
66 Two-dimensional echocardiographic diagnosis of pericardial cyst. Mayo Clin Proc 1983 0.85
67 Aldoheptoses in the O-antigenic lipopolysaccharide of Salmonella typhimurium and other gram-negative bacteria. I. Chemical synthesis of L-glycero-D-mannoheptose and beta-L-glycero-D-mannoheptopyranosyl 1-phosphate. Biochemistry 1968 0.84
68 Out-of-hospital cardiac arrest in patients without clinically significant coronary artery disease: comparison of clinical, electrophysiological, and survival characteristics with those in similar patients who have clinically significant coronary artery disease. Br Heart J 1987 0.84
69 Bacteriophage P22 is not a likely probe for zones of adhesion between the inner and outer membranes of Salmonella typhimurium. J Bacteriol 1978 0.83
70 Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia. J Am Coll Cardiol 1987 0.82
71 Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Am J Cardiol 1990 0.82
72 The Wolff-Parkinson-White syndrome: a surgical approach. Mayo Clin Proc 1982 0.82
73 Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England. J Med Genet 1991 0.82
74 Biogenesis of the outer membrane of Salmonella. Harvey Lect 1985 0.82
75 Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults. Am J Cardiol 1985 0.81
76 Improved liquid-chromatographic determination of mexiletine, an antiarrhythmic drug, in plasma. Clin Chem 1984 0.80
77 Clinical application of the signal-averaged electrocardiogram and "late potentials". J Electrocardiol 1989 0.80
78 Propafenone for the treatment of refractory complex ventricular ectopic activity. Mayo Clin Proc 1986 0.78
79 Invasive electrophysiological study in the Jervell and Lange-Nielsen syndrome. Br Heart J 1981 0.78
80 The role of frequency of atrial contraction versus atrial pressure in atrial natriuretic peptide release. J Clin Endocrinol Metab 1989 0.78
81 Follow-up of an activity-sensing, rate-modulated pacing device, including transtelephonic exercise assessment. Mayo Clin Proc 1989 0.77
82 Clinical intracardiac electrophysiologic testing: technique, diagnostic indications, and therapeutic uses. Mayo Clin Proc 1986 0.77
83 Catheter ablation of the atrioventricular conduction system in patients with supraventricular tachycardia. Mayo Clin Proc 1983 0.76
84 Value of the resting 12 lead electrocardiogram and vectorcardiogram for locating the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Br Heart J 1987 0.75
85 A multicenter experience with a bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol 1992 0.75
86 Initial and early follow-up assessment of the clinical efficacy of the multiparameter-programmable pulse generator. Pacing Clin Electrophysiol 1981 0.75
87 Cryosurgical modification of atrioventricular conduction for treatment of atrioventricular node reentrant tachycardia. Mayo Clin Proc 1988 0.75
88 Changing experience with dual chamber (DDD) pacemakers. J Am Coll Cardiol 1984 0.75
89 Two decades of cardiac pacing at the Mayo Clinic (1961 through 1981). Mayo Clin Proc 1984 0.75
90 Idiopathic lymphoplasmacytic aortic valvulitis: observations in two elderly women with unexplained aortic insufficiency. J Am Coll Cardiol 1987 0.75
91 Symptomatic "isolated" carotid sinus hypersensitivity: natural history and results of treatment with anticholinergic drugs or pacemaker. J Am Coll Cardiol 1986 0.75
92 Antitachycardia pacemaker treatment of postoperative arrhythmias in pediatric patients. Pacing Clin Electrophysiol 1991 0.75
93 Patient-activated transvenous cardiac stimulation for the treatment of supraventricular and ventricular tachycardia. Am J Cardiol 1981 0.75
94 Familial sudden death syndrome with an abnormal signal-averaged electrocardiogram as a potential marker. Am Heart J 1995 0.75
95 Incorporation of lipid vesicles by Salmonella. Ann N Y Acad Sci 1978 0.75
96 Impact of intracardiac electrophysiologic testing on the management of elderly patients with recurrent syncope or near syncope. J Am Geriatr Soc 1987 0.75
97 Apparent pacemaker failure due to reversion circuitry within the programming device. Pacing Clin Electrophysiol 1984 0.75
98 Bipolar tined polyurethane ventricular lead: a four-year experience. Pacing Clin Electrophysiol 1985 0.75
99 Suggested nomenclature code for cardiac pacing leads. Pacing Clin Electrophysiol 1985 0.75
100 Permanent antitachycardia pacing for chronic atrial tachyarrhythmias in postoperative pediatric patients. Pacing Clin Electrophysiol 1991 0.75
101 Amiodarone pulmonary toxicity. Assessment by bronchoalveolar lavage. Chest 1985 0.75